Peacock Feathers Are Stunning. They Can Also Emit Laser Beams
Scientists hope their plumage project could someday lead to biocompatible lasers that could safely be embedded in the human body.
The Very Real Case for Brain-Computer Implants
On this episode of Uncanny Valley, we dive into the heated race between two companies to build a commercial brain-computer interface.
There’s Neuralink—and There’s the Mind-Reading Company That Might Surpass It
Unlike Elon Musk's brain-computer interface, Synchron's doesn't require open-skull surgery, and it has an OpenAI chatbot baked in.
Cloning Came to Polo. Then Things Got Truly Uncivilized
A polo legend and a businessman joined forces to copy the player’s greatest horse. But with a single clone worth $800,000, some technologies are a breeding ground for betrayal.
A New Obesity Pill May Burn Fat Without Suppressing Appetite
An investigational drug developed by Eolo Pharma is showing promise in animal experiments and an early human trial. It could eventually be an alternative or add-on to popular GLP-1 medications.
Congress Demands Answers on Data Privacy Ahead of 23andMe Sale
House Democrats sent letters to the potential buyers of the genetic testing company, asking how they plan to protect customer genetic data under a change of ownership.
A Neuralink Rival Just Tested a Brain Implant in a Person
Paradromics, a brain-computer interface startup, inserted its brain implant in a person—briefly—in an early test of its technology.
The Enhanced Games Has a Date, a Host City, and a Drug-Fueled World Record
The Enhanced Games, where athletes are allowed to take performance-enhancing drugs, will host its first event in May. One “enhanced” former Olympic swimmer has already broken the 50-meter freestyle record.
Eli Lilly Sues 4 GLP-1 Telehealth Startups, Escalating War on Knockoff Drugs
Pharmaceutical giant Eli Lilly alleges the companies are selling off-brand versions of its best-selling diabetes and weight-loss drugs, Mounjaro and Zepbound.
An Experimental Obesity Pill Mimics Gastric Bypass Surgery
A novel drug that produces a temporary coating in the small intestine could be a new strategy for weight loss—and an alternative to surgeries and GLP-1 drugs.